A theme that has run through a lot of the comments about the proposed AGM centers around article 6, which reads:
"To ratify and approve the adoption of the 2016 Equity Incentive Plan."
Many of the posters are claiming that this means that a new share authorization will mainly be used to line the pockets of management, while doing nothing to move us closer to commercial success. In other words, from these people's perspective, "more of the same."
While I have no evidence to support a different approach, it seems pretty evident that whatever is happening with the EPA application, is happening through the lawyers and advocacy teams that have been hired to move this thing forward. These things are expensive, and if it works, it's worth every penny.
But what happens if Medizone runs out of money? Well, we can always appeal to the lawyers' noble spirit, and tell them how wonderful it will be if they offer their good offices pro bono in service to humanity, and help eradicate HAIs.
Good luck with that one.
Or, we close down.
Maybe we should try to find out, either from IR or whatever other connections we can use, how the additional funds will be used.
Granted, as usual it would have been smarter for the Company to be more forthcoming with a little more clarity. But if they didn't, let's try to squeeze out some more context.
